The 2nd Structure-Based Drug Design Summit explores the integration of structure-based drug design with advanced techniques such as AI, machine learning, and cryo-electron tomography to accelerate drug discovery and development.
Topics
Maximizing the structural biology toolbox for structural generation to accelerate tailored drug design
Deep diving into the potential of generative AI in structure-based drug design
Mastering the foundations of structure-based drug design for accelerated discovery
Exploring the cutting edge of structure-based drug design: Translating theory into practice through industrial applications of SBDD unlocking complex targets
Deep diving into the potential of generative AI in structure-based drug design
Utilizing structural insights bridging medicinal chemistry & computational chemistry for improved drug design
Assessing the power of cryo-electron tomography (cryo-ET) & its potential for structure-based drug design
Cultivating data acquisition & management of structural insights to maximize drug design
Leveraging AI & machine learning in structure-based drug development from predicting protein folding to optimizing experimental workflows
Who should Attend
Drug designers
Pharmaceutical researchers
Medicinal chemists
AI and machine learning experts
Biochemists
Structural biologists
Industry professionals in drug development
Venue
Revere Hotel Boston Common ,
200 Stuart Street, Boston, Massachusetts, United States
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.By clicking "Accept", you consent to our use of cookies. You can manage your preferences or learn more by clicking "Customize" or visiting our Cookies Policy page.